N/A
Completed N=211
Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops
Source: ClinicalTrials.gov NCT02138461 ↗Enrolled (actual)
211
Serious AEs
0.0%
Results posted
Sep 2014
Primary outcomePrimary: Tolerability of Medications as Measured by the COMTOL Validated Instrument — 23; 50; 26; 29 percentage of patients
Summary
This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Tolerability of Medications as Measured by the COMTOL Validated Instrument |
23; 50; 26; 29; 31; 42 | — |
Eligibility Criteria
Inclusion Criteria
- Patients with glaucoma taking either bimatoprost or latanoprost
Exclusion Criteria
- patients taking other medication or with other causes for ocular surface symptoms
Data sourced from ClinicalTrials.gov (NCT02138461). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.